These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 21800095)

  • 21. No evidence for functional selectivity of proxyfan at the human histamine H3 receptor coupled to defined Gi/Go protein heterotrimers.
    Schnell D; Burleigh K; Trick J; Seifert R
    J Pharmacol Exp Ther; 2010 Mar; 332(3):996-1005. PubMed ID: 19959746
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological properties of cardiovascular histamine H1 receptor binding sites: characterisation with 2-phenylhistamines.
    Carman-Krzan M; Krzan M; Schunack W
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Apr; 355(4):431-7. PubMed ID: 9109357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design and pharmacological characterization of VUF14480, a covalent partial agonist that interacts with cysteine 98(3.36) of the human histamine H₄ receptor.
    Nijmeijer S; Engelhardt H; Schultes S; van de Stolpe AC; Lusink V; de Graaf C; Wijtmans M; Haaksma EE; de Esch IJ; Stachurski K; Vischer HF; Leurs R
    Br J Pharmacol; 2013 Sep; 170(1):89-100. PubMed ID: 23347159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SAR exploration of the non-imidazole histamine H
    Wágner G; Mocking TAM; Ma X; Slynko I; Da Costa Pereira D; Breeuwer R; Rood NJN; van der Horst C; Vischer HF; de Graaf C; de Esch IJP; Wijtmans M; Leurs R
    Arch Pharm (Weinheim); 2023 Jan; 356(1):e2200451. PubMed ID: 36310109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histaprodifens: synthesis, pharmacological in vitro evaluation, and molecular modeling of a new class of highly active and selective histamine H(1)-receptor agonists.
    Elz S; Kramer K; Pertz HH; Detert H; ter Laak AM; Kühne R; Schunack W
    J Med Chem; 2000 Mar; 43(6):1071-84. PubMed ID: 10737740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple differences in agonist and antagonist pharmacology between human and guinea pig histamine H1-receptor.
    Seifert R; Wenzel-Seifert K; Burckstummer T; Pertz HH; Schunack W; Dove S; Buschauer A; Elz S
    J Pharmacol Exp Ther; 2003 Jun; 305(3):1104-15. PubMed ID: 12626648
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular determinants for the high constitutive activity of the human histamine H4 receptor: functional studies on orthologues and mutants.
    Wifling D; Löffel K; Nordemann U; Strasser A; Bernhardt G; Dove S; Seifert R; Buschauer A
    Br J Pharmacol; 2015 Feb; 172(3):785-98. PubMed ID: 24903527
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of the N-terminus and the E2-loop onto the binding kinetics of the antagonist mepyramine and the partial agonist phenoprodifen to H(1)R.
    Wittmann HJ; Seifert R; Strasser A
    Biochem Pharmacol; 2011 Dec; 82(12):1910-8. PubMed ID: 21933664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery of novel lead in the group of N-substituted piperazine ether derivatives with potential histamine H3 receptor activity.
    Kuder KJ; Stachnik M; Schunack W; Szymańska E; Kieć-Kononowicz K
    Med Chem; 2014; 10(6):588-99. PubMed ID: 24047214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure-based prediction of subtype selectivity of histamine H3 receptor selective antagonists in clinical trials.
    Kim SK; Fristrup P; Abrol R; Goddard WA
    J Chem Inf Model; 2011 Dec; 51(12):3262-74. PubMed ID: 22035233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 2,4-Diaminopyrimidines as histamine H4 receptor ligands--Scaffold optimization and pharmacological characterization.
    Sander K; Kottke T; Tanrikulu Y; Proschak E; Weizel L; Schneider EH; Seifert R; Schneider G; Stark H
    Bioorg Med Chem; 2009 Oct; 17(20):7186-96. PubMed ID: 19773175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclopropane-based stereochemical diversity-oriented conformational restriction strategy: histamine H3 and/or H4 receptor ligands with the 2,3-methanobutane backbone.
    Watanabe M; Kobayashi T; Hirokawa T; Yoshida A; Ito Y; Yamada S; Orimoto N; Yamasaki Y; Arisawa M; Shuto S
    Org Biomol Chem; 2012 Jan; 10(4):736-45. PubMed ID: 22120611
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and functional characterization of imbutamine analogs as histamine H3 and H4 receptor ligands.
    Geyer R; Kaske M; Baumeister P; Buschauer A
    Arch Pharm (Weinheim); 2014 Feb; 347(2):77-88. PubMed ID: 24493592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the pharmacological properties of human and rat histamine H(3)-receptors.
    Schnell D; Strasser A; Seifert R
    Biochem Pharmacol; 2010 Nov; 80(9):1437-49. PubMed ID: 20688049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular and cellular analysis of human histamine receptor subtypes.
    Seifert R; Strasser A; Schneider EH; Neumann D; Dove S; Buschauer A
    Trends Pharmacol Sci; 2013 Jan; 34(1):33-58. PubMed ID: 23254267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contribution of binding enthalpy and entropy to affinity of antagonist and agonist binding at human and guinea pig histamine H(1)-receptor.
    Wittmann HJ; Seifert R; Strasser A
    Mol Pharmacol; 2009 Jul; 76(1):25-37. PubMed ID: 19346300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interactions of recombinant human histamine H₁R, H₂R, H₃R, and H₄R receptors with 34 antidepressants and antipsychotics.
    Appl H; Holzammer T; Dove S; Haen E; Strasser A; Seifert R
    Naunyn Schmiedebergs Arch Pharmacol; 2012 Feb; 385(2):145-70. PubMed ID: 22033803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Profiling of histamine H4 receptor agonists in native human monocytes.
    Gschwandtner M; Koether B; Werfel T; Stark H; Gutzmer R
    Br J Pharmacol; 2013 Sep; 170(1):136-43. PubMed ID: 23638754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and histamine H(3) and H(4) receptor activity of conformationally restricted cyanoguanidines related to UR-PI376.
    Geyer R; Buschauer A
    Arch Pharm (Weinheim); 2011 Dec; 344(12):775-85. PubMed ID: 21987304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular determinants of selective agonist and antagonist binding to the histamine H₄ receptor.
    Istyastono EP; de Graaf C; de Esch IJ; Leurs R
    Curr Top Med Chem; 2011; 11(6):661-79. PubMed ID: 21261593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.